Blog
RSS FeedPosted by Michael Wonder on 14 Jun 2019
Ontario grants broader access to Spinraza (nusinersen) for patients living with spinal muscular atrophy
13 June 2019 - Ontario joins Saskatchewan and Quebec to give patients with spinal muscular atrophy broader access to Spinraza. ...
Posted by Michael Wonder on 22 Mar 2019
Ontario may lift ban preventing major pharmacies from selling private-label generic drugs
21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...
Posted by Michael Wonder on 21 Mar 2019
Why Ontario parents could soon be paying more for prescription drugs
22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...
Posted by Michael Wonder on 26 Feb 2019
Details of Doug Ford government’s health care overhaul, including new super agency, coming Tuesday
26 February 2019 - The Ontario government will announce its long-rumoured overhaul of the province’s health care system on Tuesday, ...
Posted by Michael Wonder on 22 Sep 2018
Ontario becomes first province to provide public funding of Tresiba for adults with diabetes mellitus
21 September 2018 - Manitoba to reimburse Tresiba following Ontario listing. ...
Posted by Michael Wonder on 02 May 2018
Ontario NDP promise take-home cancer drug coverage ahead of election
30 April 2018 - NDP Leader Andrea Horwath is promising universal access to take-home cancer drugs if her party wins ...
Posted by Michael Wonder on 26 Mar 2018
Young Canadians feeling the pinch of sky-high prescription drug prices
26 March 2018 - Use of Ontario’s public drug program has increased three fold since 2000, which suggests that young ...
Posted by Michael Wonder on 01 Mar 2018
Ontario family of toddler with rare disorder seeks funding for expensive drug
27 February 2018 - A family in Windsor, Ontario says they are being forced to choose between spending a fortune ...
Posted by Michael Wonder on 10 Jan 2018
Ontario has added Erelzi (etanercept) to public drug plan for the treatment of multiple inflammatory diseases
9 January 2018 - Erelzi has been added to public drug plan based on specific criteria in Ontario for the treatment ...
Posted by Michael Wonder on 10 May 2017
Novartis heart failure treatment Entresto (sacubitril/valsartan) now available to patients in Ontario through the public provincial drug plan
9 May 2017 - Entresto has been shown to reduce the risk of cardiovascular death and hospitalization in heart failure ...
Posted by Michael Wonder on 10 May 2017
Provincial drug plans, including Ontario and BC, make Entyvio (vedolizumab) available to treat inflammatory bowel disease
9 May 2017 - Gut-selective treatment now funded publicly for Canadians with ulcerative colitis and Crohn's disease. ...
Posted by Michael Wonder on 07 Mar 2017
Ontario cancer patient 'in limbo' over chemotherapy drug shortage
7 March 2017 - A cancer patient who was told last week that she may not receive her much-needed chemotherapy ...
Posted by Michael Wonder on 12 Oct 2016
Ontario plans new treatment for opioid addiction
12 October 2016 - Ontario plans to treat patients addicted to opioids with a safer but more expensive pharmaceutical therapy ...